Sökning: id:"swepub:oai:DiVA.org:liu-132347" >
The nociceptin/orph...
The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models
-
- Aziz, Abdul Maruf Asif (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
-
- Brothers, Shaun (författare)
- University of Miami Health System, University of Miami, Miami, USA
-
- Sartor, Gregory (författare)
- University of Miami Health System, University of Miami, Miami, USA
-
visa fler...
-
- Holm, Lovisa (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
-
- Heilig, Markus (författare)
- Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Centrum för social och affektiv neurovetenskap (CSAN),Region Östergötland, Psykiatriska kliniken
-
- Wahlestedt, Claes (författare)
- University of Miami Health System, University of Miami, Miami, USA
-
- Thorsell, Annika (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
-
visa färre...
-
(creator_code:org_t)
- 2016-08-11
- 2016
- Engelska.
-
Ingår i: Psychopharmacology. - : Springer. - 0033-3158 .- 1432-2072. ; 233:19-20, s. 3553-3563
- Relaterad länk:
-
https://liu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- RATIONALE: Alcoholism is a complex disorder in which diverse pathophysiological processes contribute to initiation and progression, resulting in a high degree of heterogeneity among patients. Few pharmacotherapies are presently available, and patient responses to these are variable. The nociceptin/orphanin FQ (NOP) receptor has been suggested to play a role both in alcohol reward and in negatively reinforced alcohol seeking. Previous studies have shown that NOP-receptor activation reduces alcohol intake in genetically selected alcohol-preferring as well as alcohol-dependent rats. NOP activation also blocks stress- and cue-induced reinstatement of alcohol-seeking behavior.OBJECTIVES: Here, we aimed to examine a novel, potent, and brain-penetrant small-molecule NOP-receptor agonist, SR-8993, in animal models of alcohol- as well as anxiety-related behavior using male Wistar rats.RESULTS: SR-8993 was mildly anxiolytic when given to naïve animals and potently reversed acute alcohol withdrawal-induced ("hangover") anxiety. SR-8993 reduced both home-cage limited access drinking, operant responding for alcohol, and escalation induced through prolonged intermittent access to alcohol. SR-8993 further attenuated stress- as well as cue-induced relapse to alcohol seeking. For the effective dose (1.0 mg/kg), non-specific effects such as sedation may be limited, since a range of control behaviors were unaffected, and this dose did not interact with alcohol elimination.CONCLUSION: These findings provide further support for NOP-receptor agonism as a promising candidate treatment for alcoholism and establish SR-8993 or related molecules as suitable for further development as therapeutics.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Beroendelära (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Substance Abuse (hsv//eng)
Nyckelord
- Nociception/orphanin FQ
- Agonist
- Wistar rat
- Alcohol
- Operant
- Reinstatement
- Elevated plus-maze
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas